Vidya A. Arankalle

8.2k total citations
182 papers, 6.2k citations indexed

About

Vidya A. Arankalle is a scholar working on Infectious Diseases, Hepatology and Epidemiology. According to data from OpenAlex, Vidya A. Arankalle has authored 182 papers receiving a total of 6.2k indexed citations (citations by other indexed papers that have themselves been cited), including 106 papers in Infectious Diseases, 106 papers in Hepatology and 89 papers in Epidemiology. Recurrent topics in Vidya A. Arankalle's work include Hepatitis Viruses Studies and Epidemiology (91 papers), Hepatitis B Virus Studies (59 papers) and Viral gastroenteritis research and epidemiology (52 papers). Vidya A. Arankalle is often cited by papers focused on Hepatitis Viruses Studies and Epidemiology (91 papers), Hepatitis B Virus Studies (59 papers) and Viral gastroenteritis research and epidemiology (52 papers). Vidya A. Arankalle collaborates with scholars based in India, United States and Netherlands. Vidya A. Arankalle's co-authors include L. P. Chobe, M. S. Chadha, Atul M. Walimbe, Suzanne U. Emerson, Akhilesh Chandra Mishra, Kavita S. Lole, Mandeep Chadha, S. S. Gandhe, K. Banerjee and A. B. Sudeep and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Lancet and SHILAP Revista de lepidopterología.

In The Last Decade

Vidya A. Arankalle

177 papers receiving 6.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Vidya A. Arankalle India 43 3.9k 3.5k 2.1k 1.7k 399 182 6.2k
Jean‐Michel Mansuy France 37 3.5k 0.9× 4.3k 1.2× 1.1k 0.5× 807 0.5× 473 1.2× 106 5.8k
Ronald E. Engle United States 45 3.0k 0.8× 6.3k 1.8× 4.1k 1.9× 431 0.2× 392 1.0× 94 8.1k
Suzan D. Pas Netherlands 35 2.2k 0.6× 1.8k 0.5× 1.7k 0.8× 360 0.2× 75 0.2× 111 4.4k
Pierre Gallian France 31 2.3k 0.6× 1.5k 0.4× 769 0.4× 879 0.5× 191 0.5× 104 3.5k
Apiradee Theamboonlers Thailand 41 2.6k 0.7× 2.1k 0.6× 4.1k 1.9× 507 0.3× 47 0.1× 227 6.3k
Dilys Morgan United Kingdom 33 2.6k 0.7× 762 0.2× 1.2k 0.6× 718 0.4× 141 0.4× 85 4.6k
Assad Safary Belgium 35 1.3k 0.3× 2.6k 0.8× 2.4k 1.1× 321 0.2× 69 0.2× 82 3.5k
Arie J. Zuckerman United Kingdom 41 1.5k 0.4× 3.9k 1.1× 5.1k 2.4× 309 0.2× 95 0.2× 285 7.1k
Yury Khudyakov United States 33 1.4k 0.4× 2.3k 0.7× 1.5k 0.7× 130 0.1× 170 0.4× 146 3.3k
Herwig Kollaritsch Austria 35 1.7k 0.4× 605 0.2× 778 0.4× 1.6k 0.9× 31 0.1× 143 3.4k

Countries citing papers authored by Vidya A. Arankalle

Since Specialization
Citations

This map shows the geographic impact of Vidya A. Arankalle's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vidya A. Arankalle with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vidya A. Arankalle more than expected).

Fields of papers citing papers by Vidya A. Arankalle

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Vidya A. Arankalle. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vidya A. Arankalle. The network helps show where Vidya A. Arankalle may publish in the future.

Co-authorship network of co-authors of Vidya A. Arankalle

This figure shows the co-authorship network connecting the top 25 collaborators of Vidya A. Arankalle. A scholar is included among the top collaborators of Vidya A. Arankalle based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Vidya A. Arankalle. Vidya A. Arankalle is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Palkar, Sonali, et al.. (2024). Dengue infection changes the expressions of CD154 and CD148 in human platelets. Virus Research. 351. 199519–199519. 2 indexed citations
2.
3.
Gunale, Bhagwat, Nicholas Farinola, Shubham Shrivastava, et al.. (2023). A Phase 1, double-blind, randomized, placebo-controlled study to evaluate the safety and immunogenicity of a tetravalent live attenuated dengue vaccine in adults. Vaccine. 41(38). 5614–5621. 2 indexed citations
4.
5.
Patil, Harshad P., et al.. (2022). Immunoglobulin G Subclass Response After Chikungunya Virus Infection. Viral Immunology. 35(6). 437–442. 2 indexed citations
6.
Gothankar, Jayashree Sachin, et al.. (2022). Time dependent decline of neutralizing antibody titers in COVID-19 patients from Pune, India and evidence of reinfection. Microbes and Infection. 24(4). 104979–104979. 3 indexed citations
7.
Patil, Harshad P., Shubham Shrivastava, Sonali Palkar, et al.. (2021). Antibody (IgA, IgG, and IgG Subtype) Responses to SARS-CoV-2 in Severe and Nonsevere COVID-19 Patients. Viral Immunology. 34(3). 201–209. 24 indexed citations
8.
Kulkarni, A. G., Nandini Malshe, Sonali Palkar, et al.. (2021). Immune Response of Indian Preterm Infants to Pentavalent Vaccine Varies With Component Antigens and Gestational Age. Frontiers in Immunology. 12. 592731–592731. 5 indexed citations
9.
Malshe, Nandini, Sonali Palkar, Ruta Kulkarni, et al.. (2019). Early disappearance of maternal anti-measles, mumps, rubella, and varicella antibodies in Indian infants. Vaccine. 37(11). 1443–1448. 11 indexed citations
10.
11.
12.
Parashar, Deepti, et al.. (2014). Assessment of qPCR, Nested RT-PCR and Elisa Techniques in Diagnosis of Chikungunya. Current Science. 107(12). 2011–2013. 6 indexed citations
13.
Devhare, Pradip, et al.. (2013). Analysis of Antiviral Response in Human Epithelial Cells Infected with Hepatitis E Virus. PLoS ONE. 8(5). e63793–e63793. 63 indexed citations
14.
Acharya, Subrat Kumar, Vishnubhatla Sreenivas, Yogesh Chawla, et al.. (2012). Treatment of Chronic Hepatitis due to Hepatitis C Virus (CH-C) in India: A Randomized Controlled Trial Comparing Daily Interferon-alfa-2b and Ribavirin with Daily Interferon-alfa-2b and Glycyrrhizin—A Multicenter Study. Journal of Clinical and Experimental Hepatology. 2(1). 10–18. 7 indexed citations
15.
16.
Arankalle, Vidya A., et al.. (2009). Virological evaluation of domestic water purification devices commonly used in India emphasizes inadequate quality and need for virological standards. Tropical Medicine & International Health. 14(8). 885–891. 8 indexed citations
17.
Lole, Kavita S., et al.. (2007). Immunogenicity of candidate hepatitis E virus DNA vaccine expressing complete and truncated ORF2 in mice. Vaccine. 25(22). 4350–4360. 35 indexed citations
18.
Murhekar, Manoj, et al.. (2000). Prevalence of hepatitis B infection among the primitive tribes of Andaman & Nicobar Islands.. PubMed. 111. 199–203. 33 indexed citations
19.
Bavdekar, Ashish, et al.. (1999). Fulminant hepatic failure: etiology, viral markers and outcome.. PubMed. 36(11). 1107–12. 43 indexed citations
20.
Arankalle, Vidya A., John R. Ticehurst, M. A. Sreenivasan, et al.. (1988). AETIOLOGICAL ASSOCIATION OF A VIRUS-LIKE PARTICLE WITH ENTERICALLY TRANSMITTED NON-A, NON-B HEPATITIS. The Lancet. 331(8585). 550–554. 110 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jean‐Michel Mansuy Breakdown of academic impact, for papers by Ronald E. Engle Breakdown of academic impact, for papers by Suzan D. Pas Breakdown of academic impact, for papers by Pierre Gallian Breakdown of academic impact, for papers by Apiradee Theamboonlers Breakdown of academic impact, for papers by Dilys Morgan Breakdown of academic impact, for papers by Assad Safary Breakdown of academic impact, for papers by Arie J. Zuckerman Breakdown of academic impact, for papers by Yury Khudyakov Breakdown of academic impact, for papers by Herwig Kollaritsch
Rankless by CCL
2026